Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients

Clinical suspicion, diagnosis and management of cardiac amyloidosis: update document and executive summary.

Revista clinica espanola·2024

Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with thiazide diuretics for decompensated heart failure) trial.

Revista clinica espanola·2024

Consensus on improving the comprehensive care of patients with acute heart failure.

Revista clinica espanola·2023

Assessment of frailty in the person with type 2 diabetes mellitus: Expert analysis.

Revista clinica espanola·2023

Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients.

Medicina (Kaunas, Lithuania)·2023

Executive summary of the 2023 update on the consensus regarding basic conduct during hospital admission for patients with acute heart failure.

Revista clinica espanola·2023

Views on pregnancy and related concerns among women with systemic lupus erythematosus: A cross-sectional study.

Lupus·2026

Clinical characteristics of patients with primary antiphospholipid syndrome and "single" antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository ("registry").

Lupus·2026

A structured primary care-led triage and referral pathway for systemic lupus erythematosus: Operational criteria and referral outcomes from a real-world rheumatology practice.

Lupus·2026

Uncertainty in illness and psychological adjustment in patients with systemic lupus erythematosus.

Lupus·2026

Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months.

Lupus·2026

Association of neutrophil-to-lymphocyte ratio with disease activity in systemic lupus erythematosus: A meta-analysis.

Lupus·2026

Cyclosporine-A Nanotherapeutics Ameliorate Lupus Nephritis by Reprogramming the Gut-Microbial Metabolic Axis and Systemic Inflammation.

ACS nano·2026

Rapid growth of a giant inflammatory polyp mimicking rectal malignancy in well-controlled Crohn's colitis: a diagnostic and therapeutic challenge.

Proceedings (Baylor University. Medical Center)·2026

A Notch signaling antagonist (DAPT) ameliorates autoimmune arthritis in mice by suppressing Th1 and Th17 immune responses.

Pakistan journal of pharmaceutical sciences·2026

Insulin-derived nodular amyloidosis at sites of injection.

Proceedings (Baylor University. Medical Center)·2026

Increased Amyloidogenic Neuronal Injury in HIV-1-infected APP-KI Alzheimer's disease mice.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Impaired regulation by purinergic signaling axis contributes to CD8+ T cell dysregulation in STAT3 gain of function.

JCI insight·2026

Related Experiment Videos

Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients

Related Concept Videos

Clinical suspicion, diagnosis and management of cardiac amyloidosis: update document and executive summary.

Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with thiazide diuretics for decompensated heart failure) trial.

Consensus on improving the comprehensive care of patients with acute heart failure.

Assessment of frailty in the person with type 2 diabetes mellitus: Expert analysis.

Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients.

Executive summary of the 2023 update on the consensus regarding basic conduct during hospital admission for patients with acute heart failure.

Views on pregnancy and related concerns among women with systemic lupus erythematosus: A cross-sectional study.

Clinical characteristics of patients with primary antiphospholipid syndrome and "single" antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository ("registry").

A structured primary care-led triage and referral pathway for systemic lupus erythematosus: Operational criteria and referral outcomes from a real-world rheumatology practice.

Uncertainty in illness and psychological adjustment in patients with systemic lupus erythematosus.

Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months.

Association of neutrophil-to-lymphocyte ratio with disease activity in systemic lupus erythematosus: A meta-analysis.

Cyclosporine-A Nanotherapeutics Ameliorate Lupus Nephritis by Reprogramming the Gut-Microbial Metabolic Axis and Systemic Inflammation.

Rapid growth of a giant inflammatory polyp mimicking rectal malignancy in well-controlled Crohn's colitis: a diagnostic and therapeutic challenge.

A Notch signaling antagonist (DAPT) ameliorates autoimmune arthritis in mice by suppressing Th1 and Th17 immune responses.

Insulin-derived nodular amyloidosis at sites of injection.

Increased Amyloidogenic Neuronal Injury in HIV-1-infected APP-KI Alzheimer's disease mice.

Impaired regulation by purinergic signaling axis contributes to CD8+ T cell dysregulation in STAT3 gain of function.

Related Experiment Videos

Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients

Related Concept Videos

Related Articles